Keywords
Farmazia-prestazioa
sendagaien finantziazioa
sendagaien prezioa.
sendagaien finantziazioa
sendagaien prezioa.
How to Cite
Umerez Igartua, M., Leunda Eizmendi, L., Landa Alberdi, J., Ercilla Liceaga, M., Urretavizcaya Anton, M., Lizardi Mutuberria, A., & Garcia de Andoin Barandiaran, J. (2020). Pharmaceutical-provision, which medicines will be paid and to what price?. Osagaiz: Osasun-Zientzien Aldizkaria, 4(2). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/321
Abstract
The pharmaceutical-provision of the public health system includes the medications that will satisfy the populations` clinical needs and will be paid with public funds. In the southern Basque Country, different organizations will participate in the selection of these medicines: the Spanish Agency for Medicine and Medical Devices in drug authorisation, the General Directorate of the Common Services Portfolio of the National Health System and Pharmacy, in specifying the list of medicines to be funded and the Interministerial Price Commission for medicines in price-fixing. The decisions of these organisations are public and can be consulted online on different websites.
Most read articles by the same author(s)
- June Landa Alberdi, Larraitz Leunda Eizmendi, Miren Ercilla Liceaga, Maitane Umerez Igartua, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Mikel Urretavizcaya Anton, Amyotrophic lateral sclerosis , Osagaiz: osasun-zientzien aldizkaria: Vol. 3 No. 2 (2019)
- Mikel Urretabizkaia, Pilar Bachiller, Josune Garcia de Andoin, Koro Andueza, Laura Basterretxea, Miren Ercilla, Maitane Umenez, Larraitz Leunda, Aitziber Lizardi, June Landa Alberdi, Garbiñe Lizeaga, Online pharmaceutical care in oncology setting: developing new pilot models , Osagaiz: osasun-zientzien aldizkaria: Vol. 4 No. 1 (2020)
- Idoia Beristain Aramendi, Miren Ercilla Liceaga, Leire Ulacia, Mikel Urretavizcaya, Aitziber Lizardi, Miren Josune Garcia de Andoin, Maitane Umerez, June Landa, Larraitz Leunda, Collaboration between pharmacist and doctor to ensure the efficacy and safe-ty of treatments in patients with HIV , Osagaiz: osasun-zientzien aldizkaria: Vol. 8 No. 1 (2024): Osagaiz: health sciences magazine
- Mikel Urretavizcaya, Miren Josune Garcia de Andoin Barandiaran, Leire Ulacia Epelde, Aitziber Lizardi Mutuberria, Maitane Umerez Igartua, June Landa Alberdi, Larraitz Leunda Ezmendi, Idoia Beristain Aramendi, Miren Ercilla Liceaga, Gene therapy: overview and therapeutic applications , Osagaiz: osasun-zientzien aldizkaria: Vol. 9 No. 1 (2025): Osagaiz: osasun-zientzien aldizkaria
- June Landa Alberdi, Larraitz Leunda Eizmendi, Miren Ercilla Liceaga, Maitane Umerez Igartua, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Mikel Urretavizcaya Anton, Idoia Beristain Aramendi, Leire Ulacia Epelde, Management of anemia and febrile neutropenia in patients treated for malignancy , Osagaiz: osasun-zientzien aldizkaria: Vol. 8 No. 1 (2024): Osagaiz: health sciences magazine
- Leire Ulacia Epelde, Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiara, Maitane Umerez Igartua, June Landa Alberdi, Larraitz Leunda Eizmendi, Mikel Urretavizcaya Anton, Idoia Beristain Aramendi, Miren Ercilla Liceaga, Psoriasis, what is it and how can we treat it? , Osagaiz: osasun-zientzien aldizkaria: Vol. 7 No. 1 (2023)
- Josune Garcia de Andoin Barandiaran, Maitane Umerez Igartua, Miren Ercilla Liceaga, June Landa Alberdi, Larraitz Leunda Eizmendi, Mikel Urretavizcaya Anton, Aitziber Lizardi Mutuberria, What can we do when the pharmaceutical-provision of the public health system doesn't include the medications for our patient clinical needs? , Osagaiz: osasun-zientzien aldizkaria: Vol. 5 No. 1 (2021)
- Aitziber Lizardi Mutuberria, Miren Josune Garcia de Andoin Barandiaran, Maitane Umerez Igartua, Miren Ercilla Liceaga, June Landa Alberdi, Larraitz Leunda Eizmendi, Mikel Urretavizcaya Anton, Undesirable effects of antineoplastic agents: which are they and how are they handled? , Osagaiz: osasun-zientzien aldizkaria: Vol. 5 No. 2 (2021)